DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Slamon DJ, Neven P, Chia S. et al.
Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: MONALEESA-3.
J Clin Oncol 2018;
36: 2465-2472
doi:10.1200/JCO.2018.78.9909
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.